General pathophysiology of macular edema

被引:63
|
作者
Scholl, Stefan
Augustin, Albert [1 ]
Loewenstein, Anat [2 ]
Rizzo, Stanislao [3 ]
Kuppermann, Baruch D. [4 ]
机构
[1] Klinikum Karlsruhe, Dept Ophthalmol, Karlsruhe, Germany
[2] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Ophthalmol, IL-69978 Tel Aviv, Israel
[3] Santa Chiara Hosp, Dept Ophthalmol, Pisa, Italy
[4] Univ Calif Irvine, Dept Ophthalmol, Irvine, CA USA
关键词
Angiotensin II; Blood-retinal barrier; Macular edema; Vascular endothelial growth factor; RETINITIS-PIGMENTOSA; VISUAL-ACUITY;
D O I
10.5301/EJO.2010.6050
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Macular edema represents a common final pathway for many ocular diseases. Related ocular disorders include diabetic retinopathy, vascular occlusions, postsurgical situations, and uveitic diseases. The key pathophysiologic process is a breakdown of the blood-retinal barrier, normally preventing water movement in the retina, thus allowing fluid to accumulate in the retinal tissue via special water fluxes. Inflammatory processes and an increase in vascular permeability play a central role. Different mechanisms, complicated by ischemic conditions, interact in a complex network. Key factors are angiotensin II, prostaglandins, and the vascular endothelial growth factor. The various pathogenetic mechanisms and their contribution to the edema process are described in detail in this article.
引用
收藏
页码:S10 / S19
页数:10
相关论文
共 50 条
  • [1] Pathophysiology of Macular Edema
    Scholl, Stefan
    Kirchhof, Janna
    Augustin, Albert J.
    OPHTHALMOLOGICA, 2010, 224 : 8 - 15
  • [2] Pathophysiology of macular edema
    Jonas, J.
    ACTA OPHTHALMOLOGICA, 2013, 91
  • [3] Targeting the Pathophysiology of Diabetic Macular Edema
    Romero-Aroca, Pedro
    DIABETES CARE, 2010, 33 (11) : 2484 - 2485
  • [4] Pathophysiology and treatment of cystoid macular edema
    Rocha, G
    Deschenes, J
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 1996, 31 (06): : 282 - 288
  • [5] Diabetic Macular Edema Pathophysiology: Vasogenic versus Inflammatory
    Romero-Aroca, Pedro
    Baget-Bernaldiz, Marc
    Pareja-Rios, Alicia
    Lopez-Galvez, Maribel
    Navarro-Gil, Raul
    Verges, Raquel
    JOURNAL OF DIABETES RESEARCH, 2016, 2016
  • [6] Pathophysiology and pharmacological targets of VEGF in diabetic macular edema
    Fogli, Stefano
    Mogavero, Selene
    Egan, Colin Gerard
    Del Re, Marzia
    Danesi, Romano
    PHARMACOLOGICAL RESEARCH, 2016, 103 : 149 - 157
  • [7] Diabetic Macular Edema: Pathophysiology and Novel Therapeutic Targets
    Das, Arup
    McGuire, Paul G.
    Rangasamy, Sampathkumar
    OPHTHALMOLOGY, 2015, 122 (07) : 1375 - 1394
  • [8] Pathophysiology of diabetic macular edema - a background for current treatment modalities
    Haritoglou, Christos
    Maier, Mathias
    Augustin, Albert
    EXPERT REVIEW OF OPHTHALMOLOGY, 2018, 13 (05) : 273 - 281
  • [9] RETINAL VESSEL DILATATION AND ELONGATION - A ROLE IN THE PATHOPHYSIOLOGY OF DIABETIC MACULAR EDEMA
    KRISTINSSON, JK
    GOTTFREDSDOTTIR, MS
    STEFANSSON, E
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1995, 36 (04) : S482 - S482
  • [10] Diabetic retinopathy and diabetic macular edema - Pathophysiology, screening, and novel therapies
    Ciulla, TA
    Amador, AG
    Zinman, B
    DIABETES CARE, 2003, 26 (09) : 2653 - 2664